SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,766 | +5.9% | 14,571 | +0.1% | 0.10% | +14.3% |
| Q2 2023 | $1,667 | -31.1% | 14,550 | -17.1% | 0.08% | -22.2% |
| Q1 2023 | $2,419 | +6.3% | 17,554 | -0.1% | 0.11% | -1.8% |
| Q4 2022 | $2,276 | -99.9% | 17,571 | -0.4% | 0.11% | +17.0% |
| Q3 2022 | $1,949,000 | +134.3% | 17,640 | +64.9% | 0.09% | +235.7% |
| Q2 2021 | $832,000 | +4.3% | 10,700 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $798,000 | -56.7% | 10,700 | -0.9% | 0.03% | -55.6% |
| Q4 2020 | $1,841,000 | +17.0% | 10,800 | -3.6% | 0.06% | +21.2% |
| Q3 2020 | $1,574,000 | -12.4% | 11,200 | 0.0% | 0.05% | +6.1% |
| Q2 2020 | $1,796,000 | +370.2% | 11,200 | -19.6% | 0.05% | +390.0% |
| Q4 2016 | $382,000 | -58.3% | 13,931 | -41.3% | 0.01% | -61.5% |
| Q4 2015 | $915,000 | – | 23,717 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |